Granger’s NGS Testing coming up “Aces”

Granger Genetics presented the results from a recently completed studies at the Fall 2016 Symposium on Advanced Wound Care held this month at Caesar’s Palace in Las Vegas, NV. Dr. William Budd, Vice-President of Science and Technology for Granger Genetics presented an abstract entitled “Use of Molecular Identification to Determine Organisms in Wounds.” According to[…]

Granger Diagnostics Introduces Wound~Seq, a Next-Generation Care Test for Diabetic Wounds

Granger Diagnostics today announced immediate availability of the first commercially-available next-generation sequencing test for wounds and infections. This test ensures discovery of ALL bacteria, ALL fungi, ALL parasites, and select viruses. The test requires only a simple swab of the wound or infected area. David G. Bostwick, MD, Chief Medical Officer, described Granger Diagnostics’ advanced[…]

Antimicrobial Resistance Genes and Modeling of Treatment Failure in Bacterial Vaginosis: Clinical Study of 289 Symptomatic Women

3/10/2016 Dr. David Bostwick and the team at AIBiotech recently published the above titled paper in the Journal of Medical Microbiology. This study is the second paper to come out of work to understand the role of bacterial flora in development of bacterial vaginosis (BV). This study evaluated the presence of anti-microbial resistance genes in[…]

American International Biotechnology, LLC Introduces GynecoloGene; The World’s First Commercially-Available Metagenomics Next-Generation Sequencing Test for Women Suffering from Bacterial Vaginosis

RICHMOND, VIRGINIA Oct. 8, 2015 — Today, American International Biotechnology, LLC presented results from GynecoloGene, the world’s first commercially-available next-generation sequencing test for bacterial vaginosis at the XXI FIGO World Congress of Gynecology and Obstetrics in Vancouver, BC, Canada. In a presentation entitled: “The Microbiome and Women’s Health”,” David G. Bostwick, MD, Chief Medical Officer,[…]